SGLT2 Inhibitors Market Scope, Size and Forecast Analysis Report 2030

Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030.

vocikok299

Jul 16, 2025 - 16:42

SGLT2 Inhibitors Market Scope, Size and Forecast Analysis Report 2030

Market Overview

The global SGLT2 inhibitors market is poised for significant growth, driven by the rising burden of chronic diseases, including type 2 diabetes and cardiovascular conditions. Expected to expand from approximately USD 18.41 billion in 2024 to around USD 30.34 billion by 2030, this market is projected to grow at a robust CAGR of 8.68% during the forecast period. The report provides comprehensive insights into market trends, competitive landscape, and strategic opportunities for stakeholders looking to invest in this burgeoning sector.

SGLT2 Inhibitors Market Key Highlights

Global market value to reach USD 30.34 billion by 2030.
Key drugs include Jardiance, Farxiga, and Invokana.
North America dominates with over 42% market share.
Increasing elderly population fueling demand for medications.
Government initiatives boost mass screening for chronic diseases.

@Get No Cost Report Sample Copy – https://www.marknteladvisors.com/query/request-sample/sglt2-inhibitors-market.html

SGLT2 Inhibitors Market Key Driver

1.) Rising Prevalence of Chronic Diseases

The alarming increase in chronic diseases globally significantly drives the SGLT2 inhibitors market. Reports indicate over 540 million adults living with type 2 diabetes, expected to rise to 640 million soon. This soaring figure reflects the urgent need for advanced therapeutic options aimed at managing these health challenges.

2.) Government Support & Mass Screening Initiatives

Countries worldwide are investing in health screening initiatives, fostering early detection and treatment of chronic disorders. These government efforts not only enhance the healthcare landscape but also stimulate demand for SGLT2 inhibitors as a frontline therapy in managing diseases like diabetes and heart issues.

3.) Next-Generation SGLT2 Inhibitors

The introduction of next-generation SGLT2 inhibitors is revolutionizing treatment options. New medications promise enhanced efficacy and safety, positioning themselves as vital components in combating type 2 diabetes and related conditions. As healthcare becomes more patient-centered, these innovative therapies are setting the stage for sustainable market growth.

View Full Research Report – https://www.marknteladvisors.com/research-library/sglt2-inhibitors-market.html

SGLT2 Inhibitors Market Segment Analysis

Divided By Drug Type

◾ Jardiance (empagliflozin)

◾ Farxiga (dapagliflozin)

◾ Invokana (canagliflozin)

◾ Inpefa (sotagliflozin)

◾ Qtern (dapagliflozin/saxagliptin)

◾ Others

Divided By Application

◾ Type 2 Diabetes

◾ Cardiovascular

◾ Chronic Kidney Disease (CKD)

◾ Others

Divided By End User

◾ Hospital Pharmacies

◾ Retail Pharmacies

◾ Online Pharmacies

Divided By Region

◾ North America

◾ South America

◾ Europe

◾ The Middle East & Africa

◾ Asia-Pacific

Looking for Global, Regional or country-specific reports on this Market? Visit our website - https://www.marknteladvisors.com/query/request-customization/sglt2-inhibitors-market.html

Competitive Landscape

◾ Astellas

◾ AstraZeneca

◾ Boehringer Ingelheim International

◾ Bristol-Myers Squibb Company

◾ Eli Lilly and Company

◾ Glenmark Pharmaceuticals

◾ Johnson & Johnson (Janssen Pharmaceuticals)

◾ Lexicon Pharmaceuticals

◾ Lupin Limited

◾ Merck

◾ Sanofi

◾ TheracosBio

◾ Others

Exploring the Research Findings

The report answers critical questions that stakeholders in the market seek to address. Key questions include:

What is the projected CAGR of the SGLT2 Inhibitors Market by 2030?
How will the SGLT2 Inhibitors Market size evolve from 2025 to 2030?
What is the forecasted value of the SGLT2 Inhibitors Market in 2030?
Which factors will drive growth in the SGLT2 Inhibitors Market by 2030?
Which regions will lead market growth through 2025–2030?
What segments are expected to expand fastest by 2030?
Who are the expected market leaders in 2025–2030?
What will be the top strategies for success in this market?
How will tech innovations reshape this market by 2030?
What investment trends are shaping the SGLT2 Inhibitors Market?
How will consumer demand shift in the next five years?
What risks could impact market growth through 2030?
Which new applications will drive future market value?
What charts show forecasted trends in this market?
What metrics should investors track from 2025 to 2030?

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

Others Report: